Navigation Links
HIV antibodies block infection by reservoir-derived virus in laboratory study
Date:8/26/2014

WHAT:

A laboratory study led by scientists from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health (NIH), lends further weight to the potential effectiveness of passive immunotherapy to suppress HIV in the absence of drug treatment. Passive immunotherapy for HIV is an experimental strategy that involves periodically administering broadly neutralizing HIV-specific antibodies (bNAbs) to control the virus. It would be advantageous to control HIV without antiretroviral drugs because of their cost, the potential for cumulative toxicities from lifelong therapy, and the difficulties some patients have adhering to drug regimens and tolerating certain drugs.

Although bNAbs have proven effective at blocking infection by various strains of HIV in the laboratory, their effect on HIV in humans, and particularly on the virus particles that hide in immune cells (called latent viral reservoirs), has been unknown.

In this study, NIH scientists obtained HIV from the latent reservoirs of 29 infected people in whom antiretroviral therapy fully inhibited viral replication. In the laboratory, the researchers found that several bNAbsparticularly PGT121, VRC01 and VRC03 effectively blocked HIV from entering the CD4+ T cells obtained from uninfected healthy donors. In addition, the scientists demonstrated in the laboratory that these antibodies could completely block HIV replication in CD4+ T cells obtained from infected individuals receiving antiretroviral therapy.

The researchers conclude that passive immunotherapy involving bNAbs individually or in combination may control HIV in the absence of antiretroviral therapy. A number of clinical trials are already underway or planned to test this hypothesis.


'/>"/>

Contact: Laura S. Leifman
laura.sivitz@nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
Source:Eurekalert  

Page: 1

Related medicine news :

1. No correlation between baby formulas and development of diabetes-associated autoantibodies
2. Antibodies from the desert as guides to diseased cells
3. NIH grantees sharpen understanding of antibodies that may cut risk of HIV infection
4. NIH scientists find mechanism that helps HIV evade antibodies, stabilize key proteins
5. Monoclonal Antibodies Market in Gastric and Esophageal Cancers to Reach USD 766 Mln by 2019, Says GBI Research in Its Report Available at MarketPublishers.com
6. Higher mortality in postmenopausal women with RA and anti-CCP antibodies
7. Maine Biotechnology Services-USDA-ARS Partnership Provides Monoclonal Antibodies to Aid in the Containment of Rift Valley Fever Virus
8. Ben-Gurion U. and Sorrento Therapeutics sign agreement to develop anti-hepatitis C virus antibodies
9. Monoclonal Antibodies Market Dealmaking in Biopharma Industry Analyzed in New Research Report at ReportsnReports.com
10. Monoclonal Antibodies Market - New Industry Research Report is Now Available for Pre-Order at Transparency Market Research
11. Research reveals how antibodies neutralize mosquito-borne virus
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
HIV antibodies block infection by reservoir-derived virus in laboratory study
(Date:10/17/2018)... ... ... have been doing this for five years. This year’s event takes place on October ... “The Harvest Festival is another way we like to give back to our families in ... Kris and Keith. , The event includes a 50/50 raffle, where half goes to ...
(Date:10/16/2018)... ... October 16, 2018 , ... ... of the Academy of Integrative Health and Medicine’s (AIHM) Visionary Award for his ... , Dr. Pizzorno was selected as AIHM’s recipient of the Visionary Award ...
(Date:10/16/2018)... ... October 16, 2018 , ... Sheba ... attorney experienced in employment law, writes frequently on employment law matters and has ... a chapter in the Health Care Compliance Professional's Manual titled “Navigating the Evolving ...
(Date:10/16/2018)... ... October 16, 2018 , ... ... and clinical research networking-technology company founded by patient-survivors, and The Avoca Group, ... in the clinical trial execution process, today announced its mutual collaboration that ...
(Date:10/13/2018)... ... October 13, 2018 , ... This World Food Day ... that it IS possible to end hunger by 2030 by breaking a GUINNESS WORLD ... several of their 28 U.S. based locations and five international locations together to break ...
Breaking Medicine News(10 mins):
(Date:10/17/2018)... ... October 17, 2018 , ... Dr. Dan ... new technique documenting the use of placental based growth factors for the treatment ... Dr. Holtzclaw, “At our DIA Dental Implant Center locations in Austin and San ...
(Date:10/17/2018)... ... October 17, 2018 , ... ... today announced that its GuidingCare® platform (Version 8.7+) has achieved NCQA Prevalidation ... included a rigorous evaluation of GuidingCare’s Population Health Management functionality. , NCQA’s ...
(Date:10/16/2018)... IRVINE, Calif. (PRWEB) , ... October 16, 2018 ... ... ophthalmic instruments, today announced its participation in the American Academy of Ophthalmology’s (AAO) ... Pan-American Association of Ophthalmology October 27-30 at McCormick Place in Chicago. AAO 2018 ...
Breaking Medicine Technology: